Neoadjuvant SGLT2 Inhibition in Localized Prostate Cancer

Clinical trial NCT04887935 · TERMINATED

Trial details

NCT number: NCT04887935
Sponsor: Washington University School of Medicine
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Prostate Cancer Cancer of Prostate

Start date: 2024-06-04
Primary completion: 2025-11-26
Enrollment: 5

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.